Marinus Pharmaceuticals Inc

NASDAQ:MRNS   3:59:52 PM EDT
5.10
+0.10 (+2.00%)
Earnings Announcements

Marinus Pharmaceuticals Reports First Quarter 2022 Results

Published: 05/12/2022 20:15 GMT
Marinus Pharmaceuticals Inc (MRNS) - Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results.
Q1 Revenue $14.2 Million.
Qtrly Loss per Share $0.52.
Revenue is expected to be $2.31 Million
Adjusted EPS is expected to be -$0.91

Next Quarter Revenue Guidance is expected to be $3.41 Million
Next Quarter EPS Guidance is expected to be -$0.97

More details on our Analysts Page.